Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Sun Pharma gains on launching AG version of Welchol Tablets in US

18-May2018

Sun Pharma gains on launching AG version of Welchol Tablets in US

Sun Pharmaceutical Industries is currently trading at Rs. 484.10, up by 4.00 points or 0.83% from its previous closing of Rs. 480.10 on the BSE.

The scrip opened at Rs. 489.70 and has touched a high and low of Rs. 489.70 and Rs. 483.30 respectively. So far 23,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 656.75 on 19-May-2017 and a 52 week low of Rs. 433.15 on 14-Aug-2017.

Last one week high and low of the scrip stood at Rs. 489.70 and Rs. 459.45 respectively. The current market cap of the company is Rs. 1,15,944.00 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.55% and 13.07% respectively.

Sun Pharmaceutical Industries through one of its wholly owned subsidiaries has launched in US, the Authorized Generic (AG) version for Daiichi Sankyo Inc.'s Welchol (colesevelam hydrochloride) 625mg tablets. Welchol Tablets recorded US sales of approximately $520 million for the 12 months ending March 2018, as per IQVIA.

The launch is pursuant to a distribution and supply agreement between Sun Pharma's wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.



Related News

View all news

Jammu & Kashmir Bank trades higher on the bourses

The Jammu & Kashmir Bank is currently trading at Rs. 42.65, up by 0.45 points or 1.07% from its previous closing of Rs. 42.20 on the BSE.The scrip opened at Rs. 42.25 and has touched a high and......

IndiGo trades in green on the BSE

Interglobe Aviation is currently trading at Rs. 843.65, up by 7.30 points or 0.87% from its previous closing of Rs. 836.35 on the BSE.The scrip opened at Rs. 848.10 and has touched a high and low of Rs.......

Mphasis slips despite reporting 37% rise in Q2 consolidated net profit

Mphasis is currently trading at Rs. 1070.00, down by 53.10 points or 4.73% from its previous closing of Rs. 1123.10 on the BSE.The scrip opened at Rs. 1107.00 and has touched a high and low of Rs. 1119.90......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......